RFCA
OFIX icon

R&F Capital Advisors’s Orthofix Medical OFIX Stock Holding History

R&F Capital Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$239K Sell
6,262
-3,288
-34% -$122K 0.06% 488
2016
Q4 		$346K Buy
+9,550
New +$363K 0.12% 268

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OCM
Oakview Capital Management Dallas, Texas $21.6M AUM 20.25% 1-Year Est. Return

R&F Capital Advisors's OFIX Position: Q1 2017 in Review

R&F Capital Advisors reduced its Orthofix Medical (OFIX) stake by 34% in Q1 2017, selling an estimated $122K and leaving 6,262 shares worth $239K. The position accounts for 0.06% of the portfolio, ranked #488.

R&F Capital Advisors first reported a position in OFIX in Q4 2016 and has held it in 2 quarters since. The position peaked at $346K in Q4 2016. 137 funds tracked by Wall St. Rank hold OFIX as of Q1 2017.

  • R&F Capital Advisors held 6,262 shares of Orthofix Medical worth $239K as of Q1 2017.
  • R&F Capital Advisors sold 3,288 Orthofix Medical shares in Q1 2017, an estimated $122K.
  • Orthofix Medical made up 0.06% of R&F Capital Advisors's portfolio in Q1 2017, its #488 holding.
  • R&F Capital Advisors first reported a position in Orthofix Medical in Q4 2016 and has held it in 2 quarters since.
  • R&F Capital Advisors's Orthofix Medical position peaked at $346K in Q4 2016.
  • 137 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.